Concepts (259)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteogenesis | 6 | 2023 | 143 | 1.380 |
Why?
|
| Parathyroid Hormone | 11 | 2023 | 43 | 1.240 |
Why?
|
| Fibroblast Growth Factors | 13 | 2022 | 72 | 1.030 |
Why?
|
| Calcium | 11 | 2023 | 575 | 0.930 |
Why?
|
| Bone and Bones | 12 | 2024 | 139 | 0.880 |
Why?
|
| Bone Diseases | 1 | 2024 | 22 | 0.860 |
Why?
|
| Osteocytes | 2 | 2020 | 12 | 0.800 |
Why?
|
| Glucuronidase | 8 | 2018 | 24 | 0.780 |
Why?
|
| Drug Delivery Systems | 1 | 2024 | 325 | 0.680 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2020 | 16 | 0.670 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2020 | 26 | 0.660 |
Why?
|
| Receptor, Parathyroid Hormone, Type 1 | 2 | 2017 | 11 | 0.650 |
Why?
|
| Histone Deacetylases | 1 | 2020 | 65 | 0.640 |
Why?
|
| Phosphates | 12 | 2017 | 93 | 0.600 |
Why?
|
| Bone Resorption | 3 | 2023 | 42 | 0.580 |
Why?
|
| Genetic Vectors | 1 | 2024 | 879 | 0.560 |
Why?
|
| Dependovirus | 1 | 2024 | 709 | 0.550 |
Why?
|
| Claudins | 1 | 2017 | 5 | 0.540 |
Why?
|
| Tight Junctions | 1 | 2017 | 20 | 0.530 |
Why?
|
| Genetic Therapy | 1 | 2024 | 791 | 0.530 |
Why?
|
| Extremities | 1 | 2017 | 43 | 0.530 |
Why?
|
| Signal Transduction | 6 | 2020 | 3035 | 0.510 |
Why?
|
| Gene Expression Regulation | 10 | 2017 | 1617 | 0.510 |
Why?
|
| Duodenum | 2 | 2006 | 42 | 0.490 |
Why?
|
| Animals | 34 | 2024 | 20659 | 0.450 |
Why?
|
| Mice | 23 | 2024 | 10844 | 0.420 |
Why?
|
| Kidney | 9 | 2023 | 446 | 0.390 |
Why?
|
| Osteoclasts | 4 | 2023 | 48 | 0.360 |
Why?
|
| Chronic Kidney Disease-Mineral and Bone Disorder | 3 | 2023 | 5 | 0.360 |
Why?
|
| Mice, Knockout | 8 | 2020 | 2109 | 0.320 |
Why?
|
| Lipid Metabolism | 2 | 2007 | 219 | 0.280 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2023 | 132 | 0.270 |
Why?
|
| Osteoblasts | 7 | 2023 | 198 | 0.260 |
Why?
|
| Calcification, Physiologic | 4 | 2015 | 20 | 0.250 |
Why?
|
| Dihydroxycholecalciferols | 1 | 2006 | 2 | 0.250 |
Why?
|
| Immobilization | 1 | 2006 | 13 | 0.250 |
Why?
|
| Homeostasis | 6 | 2023 | 368 | 0.240 |
Why?
|
| Intestinal Absorption | 1 | 2006 | 30 | 0.240 |
Why?
|
| Mice, Inbred C57BL | 7 | 2020 | 3396 | 0.240 |
Why?
|
| Vitamin D | 6 | 2023 | 140 | 0.240 |
Why?
|
| Gene Expression | 3 | 2007 | 840 | 0.230 |
Why?
|
| Gene Expression Profiling | 3 | 2020 | 770 | 0.230 |
Why?
|
| Bone Development | 2 | 2022 | 31 | 0.210 |
Why?
|
| Osteopontin | 2 | 2014 | 21 | 0.200 |
Why?
|
| Lead | 1 | 2022 | 43 | 0.190 |
Why?
|
| Stress, Psychological | 1 | 2006 | 470 | 0.190 |
Why?
|
| Gene Transfer Techniques | 1 | 2024 | 321 | 0.180 |
Why?
|
| Cell Line | 3 | 2020 | 2040 | 0.180 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2021 | 8 | 0.180 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 2 | 2023 | 4 | 0.180 |
Why?
|
| Calcitriol | 5 | 2017 | 25 | 0.180 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type IIa | 3 | 2016 | 4 | 0.180 |
Why?
|
| Promoter Regions, Genetic | 3 | 2017 | 676 | 0.170 |
Why?
|
| Parathyroid Glands | 2 | 2018 | 8 | 0.170 |
Why?
|
| Humans | 23 | 2024 | 63449 | 0.170 |
Why?
|
| Rats | 7 | 2012 | 1980 | 0.170 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2013 | 297 | 0.150 |
Why?
|
| Hyperphosphatemia | 3 | 2016 | 3 | 0.150 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2023 | 337 | 0.150 |
Why?
|
| Glycoproteins | 2 | 2012 | 187 | 0.150 |
Why?
|
| Isomaltose | 2 | 2008 | 2 | 0.140 |
Why?
|
| Oleic Acid | 2 | 2008 | 21 | 0.140 |
Why?
|
| RANK Ligand | 3 | 2023 | 22 | 0.140 |
Why?
|
| Phosphorylation | 1 | 2020 | 936 | 0.140 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 1469 | 0.140 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2018 | 127 | 0.130 |
Why?
|
| Renal Insufficiency | 1 | 2017 | 65 | 0.130 |
Why?
|
| Renal Elimination | 1 | 2016 | 3 | 0.130 |
Why?
|
| Kidney Tubules | 1 | 2016 | 21 | 0.130 |
Why?
|
| Aging | 2 | 2017 | 745 | 0.120 |
Why?
|
| Rats, Wistar | 2 | 2006 | 185 | 0.120 |
Why?
|
| Hypophosphatemia, Familial | 3 | 2011 | 4 | 0.120 |
Why?
|
| Cell Differentiation | 4 | 2023 | 1353 | 0.110 |
Why?
|
| Dental Implants | 1 | 2013 | 2 | 0.100 |
Why?
|
| Osseointegration | 1 | 2013 | 5 | 0.100 |
Why?
|
| Glycemic Index | 1 | 2013 | 23 | 0.100 |
Why?
|
| Glucose | 2 | 2007 | 467 | 0.100 |
Why?
|
| Leukocytes | 1 | 2013 | 103 | 0.100 |
Why?
|
| Titanium | 1 | 2013 | 60 | 0.100 |
Why?
|
| Calcium, Dietary | 2 | 2018 | 29 | 0.100 |
Why?
|
| Diet | 2 | 2007 | 527 | 0.090 |
Why?
|
| Dietary Proteins | 2 | 2009 | 42 | 0.090 |
Why?
|
| Anabolic Agents | 1 | 2011 | 7 | 0.090 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2012 | 48 | 0.090 |
Why?
|
| Growth Plate | 1 | 2011 | 9 | 0.090 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2012 | 61 | 0.090 |
Why?
|
| Osteochondrodysplasias | 1 | 2011 | 11 | 0.090 |
Why?
|
| Down-Regulation | 2 | 2017 | 319 | 0.090 |
Why?
|
| Calcinosis | 1 | 2012 | 85 | 0.090 |
Why?
|
| Aorta | 1 | 2012 | 114 | 0.090 |
Why?
|
| Obesity | 2 | 2009 | 1235 | 0.080 |
Why?
|
| Triiodothyronine | 1 | 2010 | 30 | 0.080 |
Why?
|
| Up-Regulation | 2 | 2011 | 374 | 0.080 |
Why?
|
| Caloric Restriction | 1 | 2009 | 18 | 0.080 |
Why?
|
| Receptors, Cell Surface | 1 | 2012 | 429 | 0.080 |
Why?
|
| Hypertriglyceridemia | 1 | 2009 | 8 | 0.080 |
Why?
|
| Quercetin | 1 | 2009 | 27 | 0.080 |
Why?
|
| Uterus | 1 | 2009 | 42 | 0.080 |
Why?
|
| Ovariectomy | 1 | 2009 | 103 | 0.080 |
Why?
|
| Calcium Channel Agonists | 1 | 2009 | 11 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 542 | 0.070 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2009 | 25 | 0.070 |
Why?
|
| Bone Density | 3 | 2017 | 134 | 0.070 |
Why?
|
| Male | 11 | 2021 | 29891 | 0.070 |
Why?
|
| Inflammation | 3 | 2023 | 1147 | 0.070 |
Why?
|
| Immunohistochemistry | 3 | 2017 | 896 | 0.070 |
Why?
|
| Fatty Liver | 1 | 2009 | 108 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2013 | 895 | 0.070 |
Why?
|
| RNA, Messenger | 4 | 2018 | 1537 | 0.070 |
Why?
|
| Caveolin 1 | 1 | 2007 | 8 | 0.070 |
Why?
|
| Phosphorus, Dietary | 1 | 2007 | 1 | 0.070 |
Why?
|
| Cordyceps | 1 | 2007 | 1 | 0.070 |
Why?
|
| Diet Therapy | 1 | 2007 | 15 | 0.070 |
Why?
|
| Primary Cell Culture | 2 | 2017 | 78 | 0.060 |
Why?
|
| Islets of Langerhans | 1 | 2008 | 279 | 0.060 |
Why?
|
| Cells, Cultured | 5 | 2011 | 2157 | 0.060 |
Why?
|
| Hydrogen Peroxide | 1 | 2006 | 78 | 0.060 |
Why?
|
| Restraint, Physical | 1 | 2006 | 40 | 0.060 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 878 | 0.060 |
Why?
|
| Dexamethasone | 1 | 2006 | 205 | 0.060 |
Why?
|
| Kidney Failure, Chronic | 1 | 2007 | 204 | 0.060 |
Why?
|
| Female | 9 | 2021 | 32881 | 0.060 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 175 | 0.060 |
Why?
|
| Symporters | 1 | 2004 | 17 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2005 | 298 | 0.050 |
Why?
|
| Antioxidants | 1 | 2005 | 252 | 0.050 |
Why?
|
| Biology | 1 | 2023 | 27 | 0.050 |
Why?
|
| Blood Glucose | 3 | 2013 | 484 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2011 | 1513 | 0.050 |
Why?
|
| Osteoporosis | 1 | 2004 | 106 | 0.050 |
Why?
|
| Mitochondria | 1 | 2006 | 371 | 0.050 |
Why?
|
| beta Catenin | 1 | 2023 | 96 | 0.050 |
Why?
|
| In Situ Hybridization | 2 | 2014 | 216 | 0.050 |
Why?
|
| Sp7 Transcription Factor | 1 | 2022 | 4 | 0.050 |
Why?
|
| Maxilla | 1 | 2022 | 3 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 2187 | 0.040 |
Why?
|
| Random Allocation | 1 | 2021 | 199 | 0.040 |
Why?
|
| Base Sequence | 3 | 2008 | 1331 | 0.040 |
Why?
|
| Cross-Over Studies | 2 | 2013 | 161 | 0.040 |
Why?
|
| Sequence Deletion | 2 | 2013 | 117 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2012 | 152 | 0.040 |
Why?
|
| Osteomalacia | 2 | 2012 | 5 | 0.040 |
Why?
|
| Sucrose | 2 | 2009 | 29 | 0.040 |
Why?
|
| Organ Specificity | 2 | 2012 | 195 | 0.040 |
Why?
|
| Hyperparathyroidism | 1 | 2018 | 7 | 0.040 |
Why?
|
| Hypercalcemia | 1 | 2018 | 8 | 0.040 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2018 | 6 | 0.040 |
Why?
|
| Hypophosphatemia | 1 | 2018 | 7 | 0.040 |
Why?
|
| Rats, Zucker | 2 | 2008 | 7 | 0.040 |
Why?
|
| HeLa Cells | 2 | 2010 | 536 | 0.040 |
Why?
|
| Hypocalcemia | 1 | 2018 | 19 | 0.040 |
Why?
|
| Immunoprecipitation | 1 | 2018 | 127 | 0.040 |
Why?
|
| Hyperplasia | 1 | 2018 | 88 | 0.030 |
Why?
|
| COS Cells | 2 | 2010 | 175 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2018 | 68 | 0.030 |
Why?
|
| Opossums | 2 | 2009 | 3 | 0.030 |
Why?
|
| Phenotype | 2 | 2011 | 1207 | 0.030 |
Why?
|
| DNA Primers | 2 | 2008 | 293 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2023 | 1186 | 0.030 |
Why?
|
| Body Weight | 2 | 2009 | 378 | 0.030 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type IIc | 1 | 2016 | 1 | 0.030 |
Why?
|
| Aging, Premature | 1 | 2016 | 2 | 0.030 |
Why?
|
| Calbindins | 1 | 2015 | 10 | 0.030 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 2015 | 3 | 0.030 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2015 | 4 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2009 | 864 | 0.030 |
Why?
|
| Calcineurin Inhibitors | 1 | 2013 | 23 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2009 | 1991 | 0.030 |
Why?
|
| Cyclosporine | 1 | 2013 | 77 | 0.030 |
Why?
|
| Uremia | 1 | 2013 | 9 | 0.030 |
Why?
|
| Calcineurin | 1 | 2013 | 47 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 207 | 0.030 |
Why?
|
| Infusion Pumps | 1 | 2011 | 8 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2012 | 302 | 0.020 |
Why?
|
| Organ Size | 1 | 2011 | 170 | 0.020 |
Why?
|
| Chondrocytes | 1 | 2011 | 42 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2011 | 93 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 402 | 0.020 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2010 | 27 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 65 | 0.020 |
Why?
|
| Response Elements | 1 | 2010 | 44 | 0.020 |
Why?
|
| Transcriptome | 1 | 2013 | 387 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2011 | 309 | 0.020 |
Why?
|
| Myocardium | 1 | 2012 | 279 | 0.020 |
Why?
|
| Time Factors | 2 | 2009 | 3768 | 0.020 |
Why?
|
| Luciferases | 1 | 2010 | 109 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 337 | 0.020 |
Why?
|
| Insulin | 1 | 2013 | 686 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2010 | 190 | 0.020 |
Why?
|
| Diet, Reducing | 1 | 2009 | 27 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2009 | 99 | 0.020 |
Why?
|
| Fasting | 1 | 2009 | 51 | 0.020 |
Why?
|
| Genotype | 1 | 2011 | 663 | 0.020 |
Why?
|
| Flavonoids | 1 | 2009 | 75 | 0.020 |
Why?
|
| Dogs | 1 | 2010 | 325 | 0.020 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2008 | 20 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2012 | 1277 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2009 | 363 | 0.020 |
Why?
|
| Dietary Carbohydrates | 1 | 2008 | 61 | 0.020 |
Why?
|
| Fibrosis | 1 | 2008 | 160 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 618 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2009 | 612 | 0.020 |
Why?
|
| Lumbar Vertebrae | 1 | 2009 | 160 | 0.020 |
Why?
|
| Sphingomyelins | 1 | 2007 | 3 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2007 | 31 | 0.020 |
Why?
|
| Secretory Vesicles | 1 | 2007 | 22 | 0.020 |
Why?
|
| Receptors, Calcitonin | 1 | 2007 | 1 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2009 | 259 | 0.020 |
Why?
|
| Cathepsin K | 1 | 2007 | 7 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2007 | 46 | 0.020 |
Why?
|
| NFATC Transcription Factors | 1 | 2007 | 20 | 0.020 |
Why?
|
| Food, Formulated | 1 | 2007 | 10 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2007 | 110 | 0.020 |
Why?
|
| Cathepsins | 1 | 2007 | 34 | 0.020 |
Why?
|
| Metabolic Syndrome | 1 | 2008 | 142 | 0.020 |
Why?
|
| Pancreas | 1 | 2007 | 151 | 0.020 |
Why?
|
| Tibia | 1 | 2007 | 70 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2007 | 61 | 0.020 |
Why?
|
| 5' Flanking Region | 1 | 2005 | 10 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2007 | 139 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2007 | 238 | 0.020 |
Why?
|
| Adipocytes | 1 | 2008 | 268 | 0.020 |
Why?
|
| Chromosomes, Mammalian | 1 | 2005 | 34 | 0.020 |
Why?
|
| Triglycerides | 1 | 2007 | 244 | 0.020 |
Why?
|
| 5' Untranslated Regions | 1 | 2005 | 29 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2005 | 80 | 0.020 |
Why?
|
| Caco-2 Cells | 1 | 2005 | 70 | 0.020 |
Why?
|
| Cholesterol | 1 | 2007 | 259 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 1592 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2006 | 369 | 0.010 |
Why?
|
| Aorta, Thoracic | 1 | 2005 | 84 | 0.010 |
Why?
|
| Cattle | 1 | 2005 | 310 | 0.010 |
Why?
|
| Exons | 1 | 2005 | 199 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2005 | 235 | 0.010 |
Why?
|
| Hyperglycemia | 1 | 2005 | 104 | 0.010 |
Why?
|
| Monocytes | 1 | 2007 | 353 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2007 | 295 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2007 | 469 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2005 | 174 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2005 | 224 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2005 | 182 | 0.010 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins | 1 | 2004 | 1 | 0.010 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type II | 1 | 2004 | 1 | 0.010 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type III | 1 | 2004 | 1 | 0.010 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type I | 1 | 2004 | 2 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2005 | 200 | 0.010 |
Why?
|
| Chromosomes, Human, X | 1 | 2004 | 36 | 0.010 |
Why?
|
| Chromosomes, Human | 1 | 2004 | 52 | 0.010 |
Why?
|
| RNA Interference | 1 | 2007 | 618 | 0.010 |
Why?
|
| Apoptosis | 1 | 2008 | 1079 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2004 | 289 | 0.010 |
Why?
|
| Liver | 1 | 2007 | 855 | 0.010 |
Why?
|
| Disease Progression | 1 | 2007 | 1172 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2009 | 1644 | 0.010 |
Why?
|
| Macrophages | 1 | 2007 | 1039 | 0.010 |
Why?
|
| Adult | 2 | 2006 | 16824 | 0.010 |
Why?
|
| Quality of Life | 1 | 2004 | 1229 | 0.010 |
Why?
|
| Aged | 1 | 2004 | 14447 | 0.000 |
Why?
|
| Middle Aged | 1 | 2004 | 17613 | 0.000 |
Why?
|